Twitter (NASDAQ: TWTR) has a few financial positives many other large tech companies do not. Among those is a second quarter balance sheet with $4.1 billion in cash and short term investments, $4.3 billion in working capital, adjusted free cash flow of $112 million, and an adjusted EBITDA of $178 million. Much of the company’s expenses for the period were stock based compensation of $133 million and amortization and depreciation of $103 million. Put another way, financially at least, Twitter is not entirely a dog. That makes it a takeover target again, now that its market cap has dropped....More>>>
Freshman Congress member Alexandria Ocasio-Cortez and veteran lawmaker Sen. Edward Markey are introducing a resolution spelling out congressional support for a Green New Deal — an ambitious plan to remake the U.S. economy and drastically reduce the nation’s greenhouse gas emissions.
The resolution largely sticks to a blueprint Ocasio-Cortez laid out when she proposed creating a House select committee to establish a Green New Deal. That framework called for generating 100 percent of the nation’s power from renewable sources, making all buildings energy efficient and eliminating....More>>>
Bitcoin bull Mike Novogratz thinks the cryptocurrency is poised for major growth.
“You’re seeing now institutions moving in,” the founder and CEO of Galaxy Digital told CNN international correspondent Paula Newton on CNNMoney’s “Markets Now” on Wednesday.
Novogratz pointed out that exchanges and big companies are starting to take the cryptocurrency more seriously.
“Starbucks and Microsoft’ll allow you to use bitcoin,” he said. “As you see more adoption of just people being comfortable with it, it feels like....More>>>
Wall Street brokerages expect that Immunomedics, Inc. (NASDAQ:IMMU) will report ($0.20) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Immunomedics’ earnings, with the lowest EPS estimate coming in at ($0.31) and the highest estimate coming in at ($0.05). Immunomedics reported earnings per share of ($0.25) in the same quarter last year, which would indicate a positive year-over-year growth rate of 20%. The business is scheduled to announce its next earnings results on Wednesday, August 15th.
Equities research analysts expect PJT Partners Inc (NYSE:PJT) to announce earnings per share (EPS) of $0.38 for the current quarter, Zacks reports. Zero analysts have provided estimates for PJT Partners’ earnings. PJT Partners reported earnings of $0.27 per share during the same quarter last year, which suggests a positive year-over-year growth rate of 40.7%. The business is scheduled to announce its next earnings results on Wednesday, August 1st.
According to Zacks, analysts expect that PJT Partners will report full year earnings of $2.29 per share for the current financial year.....More>>>